Status: current, Primitive. Date: 31-Mar 2018. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3078581000168110 | Dupixent with Needle Shield (dupilumab 300 mg / 2 mL) injection, 2 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
3078591000168113 | Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | Is a | Dupixent | true | Inferred relationship | Some | ||
Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | Is a | dupilumab 300 mg/2 mL injection, syringe | true | Inferred relationship | Some | ||
Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | has unit of use | syringe | true | Inferred relationship | Some | 1710537453 | |
Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | has Australian BoSS | dupilumab | true | Inferred relationship | Some | 1710537452 | |
Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | has intended active ingredient | dupilumab | true | Inferred relationship | Some | 1710537452 | |
Dupixent with Needle Shield 300 mg/2 mL injection, 2 mL syringe | has manufactured dose form | injection | true | Inferred relationship | Some |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set